FDAnews Drug Daily Bulletin

TITAN PHARMACEUTICALS TO RAISE $10 MILLION IN REGISTERED DIRECT OFFERING OF COMMON STOCK

March 17, 2006
A A

Titan Pharmaceuticals, Inc. today announced that it has obtained commitments to purchase shares of its common stock in a registered direct offering for gross proceeds of approximately $10 million. Under the terms of the transaction, Titan will sell approximately 3,077,000 shares of its common stock at $3.25 per share to select institutional investors. The closing of the offering is expected to take place on March 20, 2006, subject to the satisfaction of customary closing conditions.

Yahoo News (http://biz.yahoo.com/prnews/060316/nyth052.html?.v=42)